relapse leukemia

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • CD123 targeted CAR-NK cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Aug 28, 2023

Indian Children With Acute Lymphoblastic Leukemia

Not yet recruiting
  • ALL, Childhood
  • +7 more
    • New Delhi, India
    • +1 more
    Aug 22, 2022

    AML/MDS, CMML, Relapse Trial in China, Spain, United States (LP-108, LP-108 and azacitidine)

    Recruiting
    • AML/MDS
    • +5 more
    • Ann Arbor, Michigan
    • +7 more
    Feb 14, 2022

    Relapsed or Refractory Chronic Lymphocytic Leukemia

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • Cona, Ferrara, Italy
    • +26 more
    Jan 3, 2022

    Relapse Leukemia, Refractory Leukemia Trial in Shenzhen (Allogeneic CD19 CAR-T cells)

    Recruiting
    • Relapse Leukemia
    • Refractory Leukemia
    • Allogeneic CD19 CAR-T cells
    • Shenzhen, Guangdong, China
      Li Yu
    Dec 7, 2021

    Acute Myeloid Leukemia, Relapse Leukemia, Refractory Acute Myeloid Leukemia Trial in Beijing (chimeric antigen receptor T cell)

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • chimeric antigen receptor T cell
    • Beijing, Beijing, China
      Beijing Boren Hospital
    Sep 14, 2021

    Acute Myeloid Leukemia, Relapse Leukemia Trial in Guangzhou (Cladribine, G-CSF, Aclarubicin)

    Unknown status
    • Acute Myeloid Leukemia
    • Relapse Leukemia
    • Guangzhou, Guangdong, China
      Liang Wang
    Aug 18, 2019

    Stem Cell Transplant Complications, Relapse Leukemia, Refractory Leukemia Trial in Beijing (Decitabine, mBU/CY and ATG, mBU/CY)

    Recruiting
    • Stem Cell Transplant Complications
    • +2 more
    • Beijing, Beijing, China
      Peking University Institute of Hematology,Beijing
    May 27, 2019

    Relapse Leukemia, Allogeneic Stem Cell Transplantation, Immune Evasion, Tumor Trial (blood sample, bone marrow sample)

    Unknown status
    • Relapse Leukemia
    • +2 more
    • blood sample
    • bone marrow sample
    • (no location specified)
    May 24, 2019

    Hematologic Cancer, Relapse Leukemia, Relapsed Adult ALL Trial in Montreal (GLIDE)

    Unknown status
    • Hematologic Cancer
    • +8 more
    • GLIDE
    • Montreal, Quebec, Canada
      CIUSSS d l'Est-de-l'Île-de-Montréal
    Dec 4, 2017

    HLA-mismatched DSI to Treat Relapse Leukemia After HLA- Matched

    Completed
    • Relapse Leukemia
    • the first donor's stem cell
    • the second donor's stem cell
    • Beijing, Beijing, China
      Affiliated Hospital of Academy of Military Medical Sciences
    Jul 12, 2016